Dec 2 (Reuters) - GSK PLC :
* EMA FILE ACCEPTED FOR MOMELOTINIB
* EMA FILE ACCEPTED FOR MOMELOTINIB
* EUROPEAN MEDICINES AGENCY ACCEPTS MARKETING AUTHORISATION APPLICATION FOR MOMELOTINIB FOR TREATMENT OF MYELOFIBROSIS
* APPLICATION HAS DATA FROM KEY PHASE III TRIALS, INCLUDING PIVOTAL MOMENTUM TRIAL, WHICH MET ALL PRIMARY AND KEY SECONDARY EFFICACY ENDPOINTS
* A NEW DRUG APPLICATION FOR MOMELOTINIB IS CURRENTLY UNDER REGULATORY REVIEW WITH US FOOD AND DRUG ADMINISTRATION Source text for Eikon: